The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin

Journal of the Peripheral Nervous System

Volumn 16, Issue 2, 2011, Pages 150-152

  Cocito, Dario ^a   Serra, Grazia ^a   Falcone, Yolanda ^a   Paolasso, Ilaria ^a  

^a AOU San Giovanni Battista   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COST EFFECTIVENESS ANALYSIS; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG RESPONSE; HEADACHE; HUMAN; HYPERTENSION; LETTER; MUSCLE STRENGTH; PATIENT PREFERENCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION; AGED; CLINICAL TRIAL; FEMALE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFUSIONS, SUBCUTANEOUS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 80054875338     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2011.00340.x     Document Type: Letter

References (9)

1. Apolone G, Mosconi P (1998). The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025-1036. (Pubitemid 28527158)
2. Cocito D, Paolasso I, Antonini G, Benedetti L, Briani C, Comi C, Fazio R, Jann S, Mat ̀a S, Mazzeo A, Sabatelli M, Nobile- Orazio E (2010). A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 17:289-294.
3. Gardulf A, Nicolay U (2006). Replacement IgG therapy and selftherapy at home improve the health-related quality of life in patients with primary antibody deficiencies. Curr Opin Allergy Clin Immunol 6:434-442. (Pubitemid 44714156)
4. Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, Van den Bergh P, van Doorn PA, van Schaik IN (2006). European Federation of Neurological Societies/ Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 13:326-332.
5. Joint Task Force of the EFNS and the PNS (2005). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10:220-228.
6. Kö ller H, Schroeter M, Feischen H, Hartung HP, Kieseier BC (2006). Subcutaneous self-infusions of immunoglobulins as a potential therapeutic regimen in immune-mediated neuropathies. J Neurol 253:1505-1506. (Pubitemid 44950287)
7. Lee DH, Linker RA, Paulus W, Schneider-Gold C, Chan A, Gold R (2008). Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 37:406-409. (Pubitemid 351304803)
8. Nicolay U, Kiessling P, Berger M, Gupta S, Yel L, Roifman CM, Gardulf A, Eichmann F, Haag S, Massion C, Ochs HD (2006). Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol 26:65-72. (Pubitemid 43112626)
9. Viala K, Renié L, Maisonobe T, Béhin A, Neil J, Léger JM, Bouche P (2004). Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127:2010-2017. (Pubitemid 39150259)